Modern Diagnostic IPO Live GMP Today
As of 07 Feb 2026, 12:00 am IST, Modern Diagnostic SME IPO is quoting a grey market premium of +₹14 (+15.6% over the issue price), implying a listing around ₹104 per share.
| Status | Listed |
| Type | SME |
| Open Date | Dec 31, 2026 |
| Close Date | Jan 02, 2027 |
| Listing Date | Jan 07, 2026 |
| Lot Size | 3200 shares |
| Issue Size | ₹37.00 Cr |
| Date | GMP (Rs) | Change | GMP % | Est. Listing |
|---|---|---|---|---|
| Feb 07, 2026 12:00 am | +14 | ▬ 0 | +15.6% | ₹104 |
| Jan 06, 2026 12:00 am | +14 | ▼ 2 | +15.6% | ₹104 |
| Jan 05, 2026 12:00 am | +16 | — | +17.8% | ₹106 |
Modern Diagnostic IPO GMP — Detailed Analysis
What Modern Diagnostic GMP Tells Us Today
The current Grey Market Premium for Modern Diagnostic IPO is Rs 14 (15.6% over the issue price). Based on this GMP, the implied listing price hovers around Rs 104 per share. Across the 3 GMP records captured for this issue, the trend has been declining by Rs 2 — a useful directional signal for gauging investor sentiment as the listing date approaches.
How to Read the Modern Diagnostic GMP Trend
The GMP chart and history table above let you watch how unofficial demand has evolved through the bidding window. A few things worth noting when interpreting this data:
- Stable or rising GMP through bidding typically signals genuine investor demand and improves the odds of a positive listing day.
- A late-stage GMP spike (sudden jump only on the last day) is often speculative and tends to fade after listing — treat with caution.
- A declining GMP can signal either weakening sentiment or rational profit-booking by grey market players ahead of listing.
- GMP near zero or negative is a red flag — historically, IPOs that listed flat or in discount had GMP fizzle in the final days of bidding.
GMP Reliability for SME IPOs
SME IPO GMP is significantly more volatile than Mainboard GMP. Lower trading volume in the SME grey market and the smaller pool of dealers mean prices can swing sharply on small trades. Use SME GMP as a directional indicator rather than a precise price forecast — the actual listing price can deviate substantially from the implied GMP-based estimate, both upward and downward.
Modern Diagnostic IPO is expected to list on January 07, 2026. GMP signals between now and listing day are most useful as a real-time read on demand — final listing performance will also depend on subscription levels (especially QIB participation), fundamentals, and overall market conditions on the listing day.
For broader context on how GMP works as an indicator, see our explainer: What is IPO GMP?